Authors


Niklas Sandler

Latest:

Monitoring of phase transformations during processing of solid dosage forms

When a dosage form or an API is introduced to the gastrointestinal tract, or dissolution media mimicking it, a transformation from a metastable to a more stable form with lower solubility and bioavailability is possible.


Elaine Nichols

Latest:

Ensuring a culture of quality

The concept of quality should not only apply to the manufacture of the media - it should also continue throughout the product's lifetime of usage.


Paul Coombes

Latest:

The Role of 21 CFR Part 11 in the Laboratory

The benefits of using computers and electronic records are proven in most fields of modern-day work, none more so than in laboratories. The opportunities for automation have improved productivity; the computational abilities have increased the accuracy of scientific data and allowed previously difficult or impossible analytical techniques to become routine affairs. This, in turn, has led to huge advances in drug discovery and in the chemical, biochemical and physical analysis of drugs and patients.


Kai Lipinski

Latest:

Scaling Manufacturing Processes Using Single-Use Technologies

Although new single-use technologies offer the flexibility needed to overcome several challenges in ATMP production, there are many considerations and hurdles manufacturers must be aware of when scaling.


Shireesh P. Apte, PhD

Latest:

Fixed-Oil Excipient Monographs: Development of USP Fixed-Oil Reference Standards

This article summarizes the development and modernization of the United States Pharmacopeia-National Formulary (USP-NF) fixed-oil excipient monographs. This article contains bonus online-exclusive material.



Christine Vauthier

Latest:

Developing nanoparticle drug carriers

Nanoparticulate drug carriers include a class of particles made of polymers or lipids that - because of their size and chemical composition -permit systemic and local treatment.


Stephen Levine

Latest:

The Use of Acrylic Resins for Improved Aqueous Enteric Coating

Recent technology improvements have made acrylics the preferred system for the aqueous enteric coating of tablets


Gary Montague

Latest:

From data to knowledge: the challenge in bioprocess development

In biomanufacturing, multiple sensors provide a wealth of data that could be used to enhance process understanding and assist in performance improvement. This article looks at how to move from a data-rich environment to one where the data are translated to useful information that leads to knowledge and, ultimately, process improvements.



Scott Fogerty

Latest:

The Squeeze in Contract Manufacturing

The demand for CGMP production of biopharmaceuticals is at an all-time high.


Eileen E. Erdos

Latest:

Cultivating Compliance

The authors discuss how companies facing ever-evolving regulatory requirements can address and assess compliance risk in their operating practices.


Ted Acosta

Latest:

Cultivating Compliance

The authors discuss how companies facing ever-evolving regulatory requirements can address and assess compliance risk in their operating practices.


Brigitte Skalsky

Latest:

Controlling the Release of Highly Dosed and Highly Soluble Drugs

The authors formulated bupropion hydrochloride tablets with various grades of methacrylic copolymers and analyzed the properties of the resulting dosage forms. This article is part of PharmTech's supplement "Solid Dosage and Excipients 2010."


Sylvia M Findlay

Latest:

Outsourcing clinical trials: growth continues

The CRO market is experiencing two-tiered growth: firstly from pharmaceutical companies seeking to lower fixed costs by outsourcing clinical research to CROs; and secondly, from biotechnology and specialty pharmaceutical companies that lack the infrastructure to conduct trials.


Waters Corporation

Latest:

Alcami Grows Contract Manufacturing and Laboratory Business 20% With Waters Partnership

Read a compelling, detailed Case Study about how an innovation partnership with Waters Corporation enhanced Alcami’s capacity, efficiency, and compliance-readiness for their pharmaceutical manufacturing and analytical services to differentiate their offerings and drive business growth.


Les Blumberg

Latest:

How to Engage in a Strategic Outsourcing Relationship

Carefully crafted outsourcing arrangements allow companies to become powerful partners in the quest for market share.


Katrin Jess

Latest:

The extrusion and spheronization of chitosan

Chitosan is of pharmaceutical interest because of its positive attributes with respect to toxicity, biocompatibility and bioavailability.


Alexis Pellek

Latest:

Rogue Pharmacies

Government and private sector efforts take on counterfeit drugs online.


Dr Steven Bell

Latest:

Particle design using fluidized hot melt granulation

Fluidized hot melt granulation (FHMG) is an emerging technique combining the advantages of both dry and wet granulation methods, and represents an innovative continuous granulation process capable of mixing and agglomerating excipients and active pharmaceutical ingredients (APIs) to produce uniform blends of particles suitable for use in the manufacture of pharmaceutically elegant solid dosage forms.


Elaine Martin

Latest:

From data to knowledge: the challenge in bioprocess development

In biomanufacturing, multiple sensors provide a wealth of data that could be used to enhance process understanding and assist in performance improvement. This article looks at how to move from a data-rich environment to one where the data are translated to useful information that leads to knowledge and, ultimately, process improvements.


Paul Sheskey

Latest:

Scale-up trials of foam-granulation technology — high shear

The authors evaluate the scalability of foam-granulation technology using continuous foam addition in high-shear granulation equipment at the laboratory, pilot and manufacturing scales. Immediate- and controlled-release model formulations were used. Continuous and batch addition of foam were compared for the controlled-release model formulation at the manufacturing scale, and physical testing was performed on the granules and finished tablets.


P Pillai

Latest:

Mefenamic acid: new polymorph or crystal defect?

Mefenamic acid has variable bioavailability and tabletting issues because of its hydrophobic nature and poor material characteristics. Recrystallization of mefenamic acid was performed from three different solvent–solvent mixtures under differing conditions. The crystals obtained were screened for the existence of new crystal properties or polymorphic forms, then characterized further.


Marion Chatfield

Latest:

Risk-Based Intermediate Precision Studies for Analytical Procedure Validation

Validation of analytical procedures require assessment of the impact of variations within laboratories; however, guidance to study intermediate precision has been lacking. Science and risk-based principles should be used in the design of intermediate precision studies.


Claudia Aguirre-Mendez

Latest:

A Raman spectroscopic method to monitor magnesium stearate in blends and tablets

A new Raman spectroscopic method to detect magnesium stearate in powder blends and tablets is described. High-volume pharmaceutical manufacturing requires the use of lubricants to facilitate tablet ejection from compressing machines. However, lubricants may also bring a number of undesired problems that have been widely documented in pharmaceutical scientific literature. New analytical methods are needed to understand lubrication and provide process knowledge in support of FDA's process analytical technology initiative. The detection of magnesium stearate in lactose, mannitol, corn starch and other commercially important excipients is reported. The Raman spectroscopic method has a detection limit of about 0.1% (w/w) based on the 2848 cm-1 band that corresponds to the symmetric stretch of the methylene group in magnesium stearate.


H. Krarup

Latest:

Manual versus Automated Actuation of Nasal Sprays: Applications for Droplet Sizing

Automated actuation of nasal sprays removes operator bias during measurement of particle size, spray-plume geometry, and delivered dose.


Terry Thompson

Latest:

The Validation and Implementation of a Chromatography Data System

This article describes the approach used to upgrade a chromatography data system. The upgrade was required to meet the current regulatory requirements for good laboratory and good manufacturing practice. Compliance with 21 CFR Part 11 for electronic records and electronic signatures was also a major consideration. The procedures used for this project followed the software development life cycle (SDLC) and involved the co-ordination of personnel from the software vendor, the user department, information technology and quality assurance.


Rodolfo J. Romanach

Latest:

PAT — a team effort

The biggest benefit of PAT and the current FDA initiatives may be in allowing pharmaceutical scientists to use their technical capabilities to improve pharmaceutical processes.


Alan Barkely

Latest:

The Use of Acrylic Resins for Improved Aqueous Enteric Coating

Recent technology improvements have made acrylics the preferred system for the aqueous enteric coating of tablets


Brendan Fish

Latest:

Avoiding pitfalls in scaling up biopharmaceutical production

The scale-up of manufacturing processes to clinical production can be complicated and expensive, with many issues to consider. This article describes some of the common and less obvious pitfalls encountered by biopharmaceutical companies when scaling up protein production processes, and how to avoid them.